Why the study?
Do various natural products, drugs, and delivery systems protect against doxorubicin-induced toxicity?
Population
Models or patients exposed to doxorubicin
Design
Review
Authors
Loading...
Promising protective strategies summarized; leaves open which warrant prospective trials before clinical adoption.
Do various natural products, drugs, and delivery systems protect against doxorubicin-induced toxicity?
This review summarizes recent advances in strategies to mitigate doxorubicin-induced toxicity, which is a major dose-limiting factor in its clinical use.
Injac et al. (2008) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: